Articles |
From the Department of Molecular and Cellular Physiology, University of Cincinnati (Ohio).
Correspondence to Dr Nicholas Sperelakis, Department of Molecular and Cellular Physiology, University of Cincinnati, PO Box 670576, Cincinnati, OH 45267-0576.
Abstract Regulation of L-type Ca2+ channel current [ICa(L)] by cGMP-dependent protein kinase (PK-G) was investigated in ventricular myocytes from 2- to 21-day-old rats using whole-cell voltage clamp with internal perfusion. ICa(L) was elicited by a depolarizing pulse to +10 mV from a holding potential of -40 mV. Stimulated ICa(L) (by 2 µmol/L isoproterenol) was inhibited to the basal level by internal perfusion with 50 nmol/L PK-G (activated by 8Br-cGMP, 0.1 µmol/L). When ICa(L) was enhanced by Bay K 8644 (1 µmol/L), the enhanced basal ICa(L) was also reduced by PK-G. Basal ICa(L) (nonstimulated through the cAMP/cAMP-dependent protein kinase [PK-A] pathway) was also inhibited to various degrees (large, medium, or small) by internal application of PK-G (25 nmol/L). The average inhibition was 42.1% (n=36), and there were no differences in the inhibition during development. The inhibition by PK-G was blocked by the PK-G substrate peptide (cG-PKI, 300 µmol/L) and by heat inactivation of the PK-G. Relatively specific PK-G inhibitors (eg, cG-PKI and H-8) sometimes reversed the inhibition (5 of 25 cells), whereas isoproterenol stimulated ICa(L) (7 of 8 cells). When a holding potential of -80 mV was used, the inhibition produced by PK-G was much less. The inhibitory effects of PK-G were not mediated by activating phosphodiesterase or protein phosphatase but most likely by a direct phosphorylation of the Ca2+ channel or associated regulatory protein. The inhibitory effect of PK-G may be explained by a balance between activities of PK-A and PK-G in regulating the slow Ca2+ channels at two separate sites.
Key Words: Ca2+ slow channels whole-cell voltage clamp patch clamp cGMP-dependent protein kinase internal perfusion technique
This article has been cited by other articles:
![]() |
L. Yang, G. Liu, S. I. Zakharov, A. M. Bellinger, M. Mongillo, and S. O. Marx Protein Kinase G Phosphorylates Cav1.2 {alpha}1c and {beta}2 Subunits Circ. Res., August 31, 2007; 101(5): 465 - 474. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Burkard, A. G. Rokita, S. G. Kaufmann, M. Hallhuber, R. Wu, K. Hu, U. Hofmann, A. Bonz, S. Frantz, E. J. Cartwright, et al. Conditional Neuronal Nitric Oxide Synthase Overexpression Impairs Myocardial Contractility Circ. Res., February 16, 2007; 100(3): e32 - e44. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Zhang, M. Lazar, B. Molino, R. Rodriguez, T. Davidov, J. Su, J. Tse, H. R. Weiss, and P. M. Scholz Reduction in interaction between cGMP and cAMP in dog ventricular myocytes with hypertrophic failure Am J Physiol Heart Circ Physiol, September 1, 2005; 289(3): H1251 - H1257. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Su, P. M. Scholz, and H. R. Weiss Differential Effects of cGMP Produced by Soluble and Particulate Guanylyl Cyclase on Mouse Ventricular Myocytes Exp Biol Med, April 1, 2005; 230(4): 242 - 250. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Xiong, G. R. Ferrier, and S. E. Howlett Diminished Inotropic Response to Amrinone in Ventricular Myocytes from Myopathic Hamsters Is Linked to Depression of High-Gain Ca2+-Induced Ca2+ Release J. Pharmacol. Exp. Ther., August 1, 2004; 310(2): 761 - 773. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Tatsumi, N. Keira, K. Akashi, M. Kobara, S. Matoba, J. Shiraishi, S. Yamanaka, A. Mano, M. Takeda, S. Nishikawa, et al. Nitric oxide-cGMP pathway is involved in endotoxin-induced contractile dysfunction in rat hearts J Appl Physiol, March 1, 2004; 96(3): 853 - 860. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Schroder, G. Klein, B. Fiedler, M. Bastein, N. Schnasse, A. Hillmer, S. Ames, S. Gambaryan, H. Drexler, U. Walter, et al. Single L-type Ca2+ channel regulation by cGMP-dependent protein kinase type I in adult cardiomyocytes from PKG I transgenic mice Cardiovasc Res, November 1, 2003; 60(2): 268 - 277. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Sears, S. M. Bryant, E. A. Ashley, C. A. Lygate, S. Rakovic, H. L. Wallis, S. Neubauer, D. A. Terrar, and B. Casadei Cardiac Neuronal Nitric Oxide Synthase Isoform Regulates Myocardial Contraction and Calcium Handling Circ. Res., March 21, 2003; 92 (5): e52 - e59. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Fiedler, S. M. Lohmann, A. Smolenski, S. Linnemuller, B. Pieske, F. Schroder, J. D. Molkentin, H. Drexler, and K. C. Wollert Inhibition of calcineurin-NFAT hypertrophy signaling by cGMP-dependent protein kinase type I in cardiac myocytes PNAS, August 20, 2002; 99(17): 11363 - 11368. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-B. Shen and A. J. Pappano On the Role of Phosphatase in Regulation of Cardiac L-Type Calcium Current by Cyclic GMP J. Pharmacol. Exp. Ther., May 1, 2002; 301(2): 501 - 506. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Abi-Gerges, G. Szabo, A. S Otero, R. Fischmeister, and P.-F. Mery NO donors potentiate the {beta}-adrenergic stimulation of ICa,L and the muscarinic activation of IK,ACh in rat cardiac myocytes J. Physiol., April 15, 2002; 540(2): 411 - 424. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. M. Nascimento, L. Salle, J. Hoebeke, J. Argibay, and N. Peineau cGMP-mediated inhibition of cardiac L-type Ca2+ current by a monoclonal antibody against the M2 ACh receptor Am J Physiol Cell Physiol, October 1, 2001; 281(4): C1251 - C1258. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Dittrich, J. Jurevicius, M. Georget, F. Rochais, B. K. Fleischmann, J. Hescheler, and R. Fischmeister Local response of L-type Ca2+ current to nitric oxide in frog ventricular myocytes J. Physiol., July 1, 2001; 534(1): 109 - 121. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Vandecasteele, I. Verde, C. Rucker-Martin, P. Donzeau-Gouge, and R. Fischmeister Cyclic GMP regulation of the L-type Ca2+ channel current in human atrial myocytes J. Physiol., June 1, 2001; 533(2): 329 - 340. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Abi-Gerges, R. Fischmeister, and P.-F. Mery G protein-mediated inhibitory effect of a nitric oxide donor on the L-type Ca2+ current in rat ventricular myocytes J. Physiol., February 15, 2001; 531(1): 117 - 130. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Klein, H. Drexler, and F. Schroder Protein kinase G reverses all isoproterenol induced changes of cardiac single L-type calcium channel gating Cardiovasc Res, December 1, 2000; 48(3): 367 - 374. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nakamura, M. Sunagawa, T. Kosugi, and N. Sperelakis Actin filament disruption inhibits L-type Ca2+ channel current in cultured vascular smooth muscle cells Am J Physiol Cell Physiol, August 1, 2000; 279(2): C480 - C487. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yuasa, H. Michibata, K. Omori, and N. Yanaka A Novel Interaction of cGMP-dependent Protein Kinase I with Troponin T J. Biol. Chem., December 24, 1999; 274(52): 37429 - 37434. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. F. Du Toit, C. A. Muller, J. McCarthy, and L. H. Opie Levosimendan: Effects of a Calcium Sensitizer on Function and Arrhythmias and Cyclic Nucleotide Levels during Ischemia/Reperfusion in the Langendorff-Perfused Guinea Pig Heart J. Pharmacol. Exp. Ther., August 1, 1999; 290(2): 505 - 514. [Abstract] [Full Text] |
||||
![]() |
E. Carmeliet Cardiac Ionic Currents and Acute Ischemia: From Channels to Arrhythmias Physiol Rev, July 1, 1999; 79(3): 917 - 1017. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. J. JI, B. K. FLEISCHMANN, W. BLOCH, M. FEELISCH, C. ANDRESSEN, K. ADDICKS, and J. HESCHELER Regulation of the L-type Ca2+ channel during cardiomyogenesis: switch from NO to adenylyl cyclase-mediated inhibition FASEB J, February 1, 1999; 13(2): 313 - 324. [Abstract] [Full Text] |
||||
![]() |
S. T Rapundalo Cardiac protein phosphorylation: functional and pathophysiological correlates Cardiovasc Res, June 1, 1998; 38(3): 559 - 588. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Han, I. Kubota, O. Feron, D. J. Opel, M. A. Arstall, Y.-Y. Zhao, P. Huang, M. C. Fishman, T. Michel, and R. A. Kelly Muscarinic cholinergic regulation of cardiac myocyte ICa-L is absent in mice with targeted disruption of endothelial nitric oxide synthase PNAS, May 26, 1998; 95(11): 6510 - 6515. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Depre, V. Gaussin, S. Ponchaut, Y. Fischer, J.-L. Vanoverschelde, and L. Hue Inhibition of myocardial glucose uptake by cGMP Am J Physiol Heart Circ Physiol, May 1, 1998; 274(5): H1443 - H1449. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. L. Kanagy Increased vascular responsiveness to alpha 2-adrenergic stimulation during NOS inhibition-induced hypertension Am J Physiol Heart Circ Physiol, December 1, 1997; 273(6): H2756 - H2764. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-L. Balligand and P. J. Cannon Nitric Oxide Synthases and Cardiac Muscle : Autocrine and Paracrine Influences Arterioscler Thromb Vasc Biol, October 1, 1997; 17(10): 1846 - 1858. [Abstract] [Full Text] |
||||
![]() |
H. Ikenouchi, K. Kangawa, H. Matsuo, and Y. Hirata Negative Inotropic Effect of Adrenomedullin in Isolated Adult Rabbit Cardiac Ventricular Myocytes Circulation, May 6, 1997; 95(9): 2318 - 2324. [Abstract] [Full Text] |
||||
![]() |
R. Kumar, T. Namiki, and R. W. Joyner Effects of cGMP on L-type calcium current of adult and newborn rabbit ventricular cells Cardiovasc Res, March 1, 1997; 33(3): 573 - 582. [Abstract] [PDF] |
||||
![]() |
R. A. Kelly, J.-L. Balligand, and T. W. Smith Nitric Oxide and Cardiac Function Circ. Res., September 1, 1996; 79(3): 363 - 380. [Full Text] |
||||
![]() |
X. Han, L. Kobzik, J.-L. Balligand, R.A. Kelly, and T.W. Smith Nitric Oxide Synthase (NOS3)–Mediated Cholinergic Modulation of Ca2+ Current in Adult Rabbit Atrioventricular Nodal Cells Circ. Res., June 1, 1996; 78(6): 998 - 1008. [Abstract] [Full Text] |
||||
![]() |
J. W. Wegener, H. Nawrath, W. Wolfsgruber, S. Kuhbandner, C. Werner, F. Hofmann, and R. Feil cGMP-Dependent Protein Kinase I Mediates the Negative Inotropic Effect of cGMP in the Murine Myocardium Circ. Res., January 11, 2002; 90(1): 18 - 20. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1995 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |